A universal respiratory syncytial virus (RSV) immunization program using Sanofi’s Beyfortus (nirsevimab) was associated with ...

Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season First study showing that infants immunized against RSV in their first season had fewer RSV ...

Each year, the World Health Organization (WHO) partakes in World Immunization Week, a period of reflection, raising awareness, and future planning surrounding global action required to combat ...

Immunization programs are among the most essential instruments and achievements in public health globally, clubbed together with clean water and better healthcare access in their importance for longer ...